These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 27304055)

  • 1. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
    Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to Consider Rare Genetic Variants in Personalized Drug Therapy.
    Lauschke VM; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2018 May; 103(5):745-748. PubMed ID: 29313952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic content of commercial genome-wide genotyping arrays.
    Lemieux Perreault LP; Zaïd N; Cameron M; Mongrain I; Dubé MP
    Pharmacogenomics; 2018 Oct; 19(15):1159-1167. PubMed ID: 30272537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics, precision medicine, and implications for anesthesia care.
    Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMET-Miner: Efficient discovery of association rules from pharmacogenomic data.
    Agapito G; Guzzi PH; Cannataro M
    J Biomed Inform; 2015 Aug; 56():273-83. PubMed ID: 26092773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
    Lauschke VM; Milani L; Ingelman-Sundberg M
    AAPS J; 2017 Nov; 20(1):4. PubMed ID: 29181807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.
    Kim B; Yoon DY; Lee S; Jang IJ; Yu KS; Cho JY; Oh J
    Transl Clin Pharmacol; 2021 Sep; 29(3):135-149. PubMed ID: 34621706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine: going to the dogs?
    Mealey KL; Martinez SE; Villarino NF; Court MH
    Hum Genet; 2019 May; 138(5):467-481. PubMed ID: 31032534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect.
    Sadee W
    Pharmacogenomics; 2011 May; 12(5):675-80. PubMed ID: 21619429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity.
    Rumiato E; Boldrin E; Amadori A; Saggioro D
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):483-8. PubMed ID: 23760813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
    Ahmed S; Zhou Z; Zhou J; Chen SQ
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives.
    Arbitrio M; Di Martino MT; Scionti F; Barbieri V; Pensabene L; Tagliaferri P
    High Throughput; 2018 Dec; 7(4):. PubMed ID: 30567415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY; Lee MT; Chen YT
    Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
    Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G
    Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future prospects for pharmacogenetics in the quest for personalized medicine.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters].
    Zhou Q; Yu LS; Zeng S
    Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.